1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

References:
1. Kramer, J.C., Klein, D.F., & Fink, M. (1961). Withdrawal symptoms following
discontinuation of imipramine therapy. American Journal of Psychiatry, 118, 548–550.
2. Haddad, P. (2001). Antidepressant discontinuation syndromes. Drug Safety, 24(3), 183-
197.
3. Hollister, L.E., Motzenbecker, F,P,, & Degan, R.O. (1961). Withdrawal reactions from
chlordiazepoxide („Librium“). Psychopharmacologia, 2, 63-68.
4. Medawar, C., Hardon, A. (2004). Medicines out of control. The Netherlands: Aksant.
5. European Commission. Public health. Available from: http://ec.europa.eu/health/humanuse/pharmacovigilance/index_en.htm
accessed 16. September 2012
6. Lexchin J. in Temple, N.J., & Thompson, A. (2007). Excessive Medical Spending.
Facing the challenges. Oxon, UK: Radcliffe Publishing Ldt.
7. Abraham, J. (2003a). The science and politics of Medicines control. Drug Safety, 26 (3),
135-143.
8. Lader, M. (1989). Benzodiazepine dependence. International Review of Psychiatry, 1,
149-156.
9. McGoye, L. (2007). On the will to ignorance in bureaucracy. Economy and Society,;36,
212-235.
10. Haddad, P. (1998). The SSRI discontinuation syndrome. Journal of
Psychopharmacology, 12(3), 305-313.
11. Healy, D. (2004). Let them eat Prozac. New York and London: New York University
Press.
12. Healy, D. (2003). SSRIs and withdrawal/dependence Briefing Paper 20.06.2003 at
www.socialaudit.co.uk
13. Haddad, P. (2005). Do antidepressants cause dependence Epidemiologia e Psichiatria
Sociale, 14, 58-62.
14. European Medicines Agency (1999/2000). EMEA/CPMP/2775/99. Retrieved from:
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/
WC500003357.pdf
15. WHO (2003). Technical Report Series no 915. WHO Expert Committee on Drug
Dependence. Thirty third report. WHO Geneve.